Pablo Zuanic

The recent equity raises by Canopy Growth (NASDAQ: CGC) and Columbia Care (OTC: CCHWF) have sparked curiosity about which multi-state operators (MSOs) may follow suit. In its latest report, Zuanic & Associates (Z&A) delves into the financial net debt metrics of 20 MSOs to identify potential...

Zuanic & Associates' latest report outlines a roadmap for the SAFE Banking Act in the US cannabis industry, emphasizing the significance of rescheduling, US exchange uplisting, and a potential "Cole Memo II" (Garland Memo) as more critical catalysts than the SAFE Act itself. Join...

Planet 13 Holdings Inc. (OTC: PLNHF) (OTC: PLTH) is aiming to acquire VidaCann, which operates 26 dispensaries and holds the ninth-largest retail network in Florida. While recreational legalization is the anticipated catalyst for further market growth, Florida's medical marijuana market is...

The Florida cannabis market is experiencing impressive growth, setting the stage for the potential legalization of recreational use. As it stands, Florida's medical marijuana market already boasts an impressive valuation of over $1.4 billion with a remarkable volume growth rate...

Maryland stands as a shining example of a medical cannabis state transitioning smoothly into the recreational market. According to a financial report by Zuanic & Associates, (Z&A), this transition has been particularly beneficial for incumbent medical cannabis players, who have witnessed a...

US legal cannabis sales are predicted to exceed $28 billion in 2023, with promising regulatory developments such as the recommendation to "reschedule" cannabis by the HHS. Canada's cannabis exports have surged to C$160 million, a 50% increase year-on-year, and with new international...

As the cannabis industry continues to evolve, revealing data analysis by Zuanic & Associates sheds light on a captivating paradox: while flower sales have shown signs of growth, their dominance has waned, unveiling a changing landscape. Over nearly three years, flower sales have bloomed by 62...

The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal law. Assistant Secretary for Health Rachel Levine's letter triggered a much-needed rally in cannabis stocks. In a recent analyst note, a...

The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the Controlled Substances Act set off ripples across the cannabis market. One day following Wednesday's news, MSOS ETF (ARCA: MSOS) surged by 21%. Notable companies also...

Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has ignited significant market reactions. On the day following the report, MSOS ETF (ARCA: MSOS) surged...

Zuanic & Associates' recent report unveils the movers and shakers in the flower segment, shedding light on their market shares, pricing strategies and fortunes. The second quarter of 2023 saw some intriguing shifts in the sector. When it comes to market leaders in the flower segment,...

In a recent report by Zuanic & Associates, a comprehensive analysis of Canada's cannabis industry highlights both promising growth trends and concerning gaps in comparison to the United States. The data reveals that while Canada's cannabis market is experiencing decent growth, it falls...

The introduction of recreational cannabis sales has brought about significant shifts in the medical marijuana (MMJ) landscape across several states, impacting sales and patient counts. In many states, MMJ sales have experienced double-digit declines following the onset of recreational sales....

Maryland's recreational cannabis sales, which began in July 2023, surged impressively in just the first month, reaching $87.3 million. According to analysis firm, Zuanic & Associates, this significant growth, although promising, falls slightly short of expectations given the state's...

The Canadian cannabis market is abuzz with competition. The latest data from Hifyre, as analyzed by Zuanic & Associates, highlights a heated race in the pre-roll segment. In the second quarter of 2023, a staggering 1,475 pre-roll SKUs were registered, originating from a diverse pool of 148...